Study reveals that women with Hypoactive Sexual Desire Disorder (HDSS) show a “top-down” brain inhibition pattern, while men do not, suggesting significant sexual dimorphism in brain responses to sexual stimuli.
FDA rejects Intercept’s NASH drug, prompting a pivot
The Food and Drug Administration rejected Intercept Pharmaceuticals’ investigational treatment for NASH on Thursday, derailing what would have been the first approved medicine for a
June 22, 2023